The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis.

Martina PetruzzoAntonio ReiaGiorgia T ManiscalcoFabrizio LuisoRoberta LanzilloCinzia Valeria RussoAntonio CarotenutoLia AllegoricoRaffaele PalladinoVincenzo Brescia MorraMarcello Moccia

Published in: European journal of neurology (2020)

Higher cardiovascular risk was associated with higher risk of relapses, disability, and DMT escalation in MS. Early identification, correction, and treatment of cardiovascular comorbidities should be carefully considered within MS management.

Keyphrases

multiple sclerosis
mass spectrometry
white matter
ms ms
clinical trial
combination therapy
bioinformatics analysis